Table 3. Top ten of significant pathway associated with shoulder impingement syndrome.
| Pathway | P value | FDR q value |
|---|---|---|
| MANALO_HYPOXIA_UP | 5.00× 10−5 | 0.018 |
| NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON | 5.00× 10−5 | 0.021 |
| BECKER_TAMOXIFEN_RESISTANCE_DN | 1.00× 10−4 | 0.018 |
| DELYS_THYROID_CANCER_DN | 1.00× 10−5 | 0.002 |
| DING_LUNG_CANCER_BY_MUTATION_RATE | 1.00× 10−5 | 0.018 |
| GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP | 1.00× 10−5 | 0.035 |
| KEGG_CALCIUM_SIGNALING_PATHWAY | 1.00× 10−5 | 0.018 |
| KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.00× 10−5 | 0.015 |
| WEI_MIR34A_TARGETS | 1.00× 10−5 | 0.018 |
| IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN | 1.49× 10−5 | 0.018 |